Home › NDC Lookup › RxCUI directory › RxCUI 205331

Miglitol 100 MG Oral Tablet — RxCUI 205331

Name: Miglitol 100 MG Oral Tablet (RxCUI 205331)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 205331 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI205331

Official nameMiglitol 100 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped6

Package NDCs mapped15

Reported Medicaid activity (SDUD)52 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Miglitol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Miglitol works differently from many diabetes medications. Instead of telling your pancreas to make more insulin, it slows down the digestion of carbohydrates in your small intesti...
What exactly does miglitol do — and is it like other diabetes pills?
Take it right when you sit down to eat — at the very start of each main meal, three times a day. If you take it before your meal or forget until partway through, the timing matters...
When exactly should I take my miglitol tablet?

📖 Read our full Miglitol guide →

🕸️ Concept Web — How Miglitol 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Miglitol 100 MG Oral Tablet RxCUI 205331 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Miglitol 30009 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Miglitol Oral Tablet 372926 SCDF
- Miglitol Oral Product 1157268 SCDG
- Miglitol Pill 1157269 SCDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Miglitol 100 MG 316304 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Miglitol 100 MG SCDC · 316304
Miglitol Oral Tablet SCDF · 372926
Miglitol Oral Product SCDG · 1157268
Miglitol Pill SCDG · 1157269

📦 FDA Products & Package NDCs

6 products · 15 package NDCs

15 package NDCs map to RxCUI 205331 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69367-0303-01	100 TABLET, COATED in 1 BOTTLE (69367-303-01)	Miglitol	Westminster Pharmaceuticals, LLC	2021-01-15
69367-0304-01	100 TABLET, COATED in 1 BOTTLE (69367-304-01)	Miglitol	Westminster Pharmaceuticals, LLC	2021-01-15
69367-0305-01	100 TABLET, COATED in 1 BOTTLE (69367-305-01)	Miglitol	Westminster Pharmaceuticals, LLC	2021-01-15
71205-0935-00	100 TABLET, COATED in 1 BOTTLE (71205-935-00)	Miglitol	Proficient Rx LP	2021-03-01
71205-0935-30	30 TABLET, COATED in 1 BOTTLE (71205-935-30)	Miglitol	Proficient Rx LP	2021-03-01
71205-0935-60	60 TABLET, COATED in 1 BOTTLE (71205-935-60)	Miglitol	Proficient Rx LP	2021-03-01
71205-0935-90	90 TABLET, COATED in 1 BOTTLE (71205-935-90)	Miglitol	Proficient Rx LP	2021-03-01
71205-0936-00	100 TABLET, COATED in 1 BOTTLE (71205-936-00)	Miglitol	Proficient Rx LP	2021-03-01
71205-0936-30	30 TABLET, COATED in 1 BOTTLE (71205-936-30)	Miglitol	Proficient Rx LP	2021-03-01
71205-0936-60	60 TABLET, COATED in 1 BOTTLE (71205-936-60)	Miglitol	Proficient Rx LP	2021-03-01
71205-0936-90	90 TABLET, COATED in 1 BOTTLE (71205-936-90)	Miglitol	Proficient Rx LP	2021-03-01
71205-0937-00	100 TABLET, COATED in 1 BOTTLE (71205-937-00)	Miglitol	Proficient Rx LP	2021-03-01
71205-0937-30	30 TABLET, COATED in 1 BOTTLE (71205-937-30)	Miglitol	Proficient Rx LP	2021-03-01
71205-0937-60	60 TABLET, COATED in 1 BOTTLE (71205-937-60)	Miglitol	Proficient Rx LP	2021-03-01
71205-0937-90	90 TABLET, COATED in 1 BOTTLE (71205-937-90)	Miglitol	Proficient Rx LP	2021-03-01

Observed labelers: Proficient Rx LP (12) · Westminster Pharmaceuticals, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.